BioTechnology: An Indian Journal
ISSN (PRINT): 0974-7435

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Anti-tuberculosis Drug Resistance

 Medication safe TB is brought about by TB microscopic organisms that are impervious to in any event one first-line hostile to TB tranquilize. Multidrug-safe TB (MDR TB) is impervious to more than one enemy of TB sedate and at any rate isoniazid (INH) and rifampin (RIF). MDR-TB is brought about by strains of Mycobacterium tuberculosis that are impervious to in any event rifampicin and isoniazid, two key medications in the treatment of the malady. Since 2006, it has been perceived the nearness of significantly increasingly safe strains of M. tuberculosis marked as broadly tranquilize safe (XDR)- TB. As per the report, roughly 20% of TB cases universally are assessed to be impervious to in any event one of the first-or second-line hostile to TB medications, and 5% are impervious to both isoniazid and rifampicin, the most impressive and generally utilized anti-microbials in first-line treatment

High Impact List of Articles

Relevant Topics in General Science

Awards Nomination

Table of Contents

Google Scholar citation report
Citations : 875

BioTechnology: An Indian Journal received 875 citations as per Google Scholar report

Citation image

Indexed In

  • CASS
  • Google Scholar
  • Open J Gate
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Secret Search Engine Labs
  • Euro Pub
  • ICMJE

View More

For Authors

For Librarians

Flyer

Open Access Journals